Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 30.27

From 52W high−53.70%

Volume8.36M

Market capCNY 35.25B

P/E (TTM)54.1x

P/S (TTM)7.5x

Div yield1.81%

Key dataSep 18, 2026

Open

CNY 30.27

From 52W high

−53.70%

Volume

8.36M

Market cap

CNY 35.25B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

30.0x

P/E (TTM)

54.1x

RSI (14)

39.0

MomentumView details →

1D Return

−3.24%

YTD Return

−38.65%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

54.1x

EV/EBITDA

30.0x

EV/Sales

7.3x

P/S (TTM)

7.5x

P/B (TTM)

4.1x

ProfitabilityView details →

Gross Margin

75.12%

Net Margin

14.97%

EBITDA Margin

24.47%

ROE (TTM)

7.39%

ROA (TTM)

5.93%

Asset Turnover

0.40x

GrowthView details →

Revenue YoY

+13.44%

EPS YoY

+11.73%

FCF YoY

−93.03%

Revenue CAGR 3Y

+7.72%

EPS CAGR 3Y

+0.00%

EBITDA YoY

—

MomentumView details →

1D Return

−3.24%

YTD Return

−38.65%

1Y Return

−41.96%

RSI (14)

39.0

vs 50D SMA

−9.08%

vs 200D SMA

−32.38%

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

2.34x

Quick Ratio

2.03x

Div Yield

1.81%

Div Rate

CNY 0.55

Div Growth 1Y

+10.00%

EarningsView details →

EPS (Actual)

CNY 0.15

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

4.52B

Net Income (TTM)

676.45M

Op. CF (TTM)

1.07B

Next earningsOct 27, 2026 →

Latest newsMore news →

Shenzhen Salubris Pharmaceuticals updated and resubmitted its H-share listing application to the Hong Kong Stock Exchange on September 3, 2026, for a proposed issuance of overseas listed shares (H shares) and main board listing.17d ago

Similar companies

水晶光电002273.SZ 横店东磁002056.SZ 万向钱潮000559.SZ 兆驰股份002429.SZ 佛塑科技000973.SZ 国科微300672.SZ Find similar companies →

Latest newsMore news →

Shenzhen Salubris Pharmaceuticals updated and resubmitted its H-share listing application to the Hong Kong Stock Exchange on September 3, 2026, for a proposed issuance of overseas listed shares (H shares) and main board listing.17d ago